{"product_id":"novozymes-marketing-mix","title":"Novozymes Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGet Inspired by a Complete Brand Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eNovozymes leverages biotech-driven product innovation, premium value-based pricing, specialized B2B distribution channels, and targeted sustainability-focused promotion to dominate industrial enzymes and biosolutions—discover how these elements align to drive market leadership. Get the full 4Ps Marketing Mix Analysis in an editable, presentation-ready format for instant use in strategy, benchmarking, or coursework.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustrial Enzyme Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovozymes Industrial Enzyme Solutions target household care and textile producers with high-performance catalysts that boost cleaning and enable cold-water washing; by end-2025 the portfolio emphasizes cold-wash and concentrated-detergent enzymes, supporting ~20% lower washing temperatures and up to 30% smaller dosages, helping clients cut energy use and chemical input—Novozymes reported enzyme sales of DKK 11.2bn in 2024, with industrial enzymes a key growth driver.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAgricultural Biologicals and Bio-solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovozymes’ Agricultural Biologicals and Bio-solutions comprise microorganisms and enzymes that raise yields and restore soil health naturally, reducing chemical input needs; bio-agents improved yields by 8–12% in independent 2024 trials on corn and soy. The 2025 portfolio adds advanced bio-fungicides and bio-stimulants for corn, soy, and wheat, targeting a market Novozymes valued at ~$1.8B in 2024. These solutions cut nitrogen fertilizer use by up to 20% and lower pesticide costs, supporting farmers’ ESG goals and driving recurring revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFood and Beverage Bio-Innovation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovozymes supplies enzymes that boost yields and nutrition across food lines—extending baked goods shelf life by up to 30%, improving dairy texture, and enabling plant-based meat with higher protein retention; enzyme sales in BioInnovation rose ~8% in 2024, contributing to Novozymes’ 2024 revenue of DKK 20.5bn. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBioenergy and Technical Applications\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eNovozymes Bioenergy and Technical Applications enzymes convert agricultural waste and starch into bioethanol, boosting conversion rates by up to 15–25% versus legacy enzymes and cutting processing costs by ~10% (2024–2025 pilot data).\u003c\/p\u003e\n\u003cp\u003eAdvanced cellulases and amylases enable efficient first‑ and second‑generation biofuels, supporting projected transport decarbonization where biofuels must supply ~8–10% of road fuel by 2030 per IEA scenarios; this segment drove ~€120m in 2024 revenue for industrial enzymes.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigher yields: +15–25% conversion\u003c\/li\u003e\n\u003cli\u003eCost reduction: ~10% lower processing costs\u003c\/li\u003e\n\u003cli\u003eMarket impact: supports 8–10% biofuel share by 2030\u003c\/li\u003e\n\u003cli\u003eFinancials: ~€120m 2024 segment revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHuman Health and Nutrition Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpfollowing the strategic integration with chr. hansen novozymes human health and nutrition offers probiotics enzymes for gut immune support metabolism via supplements functional foods targeting a global wellness market projected at by\u003e\n\u003cpthese biologics are supported by over clinical studies and contributed to novozymes segment revenue growth of in driven rising demand apac north america.\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\u003cli\u003ePost-merger product range: probiotics, digestive enzymes, synbiotics\u003c\/li\u003e\u003cli\u003eClinical evidence: 100+ trials\u003c\/li\u003e\u003cli\u003eMarket size: ~$275B (2025 est.)\u003c\/li\u003e\u003cli\u003e2024 segment growth: ~8%\u003c\/li\u003e\n\u003c\/pthese\u003e\u003c\/pfollowing\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovozymes boosts yields, cuts costs \u0026amp; energy across enzymes, ag‑bio, bioenergy \u0026amp; health\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovozymes’ product mix (2024–2025) centers on industrial enzymes (DKK 11.2bn sales 2024), agri-biologics (~$1.8bn target market 2024), bioenergy enzymes (€120m 2024), and human health (post‑Chr. Hansen, ~$275bn wellness market 2025), delivering 8–25% performance gains and 10–30% cost\/energy reductions in target use cases.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2024 revenue\u003c\/th\u003e\n\u003cth\u003eKey impact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndustrial enzymes\u003c\/td\u003e\n\u003ctd\u003eDKK 11.2bn\u003c\/td\u003e\n\u003ctd\u003e-20% wash temp, -30% dosage\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAgricultural biologics\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e+8–12% yields, -20% N fertilizer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBioenergy\u003c\/td\u003e\n\u003ctd\u003e€120m\u003c\/td\u003e\n\u003ctd\u003e+15–25% conversion, -10% cost\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHuman health\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e100+ trials, 8% seg. growth 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into Novozymes’ Product, Price, Place, and Promotion strategies, ideal for managers, consultants, and marketers seeking a clear breakdown of the company’s marketing positioning grounded in real practices and competitive context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Novozymes' 4P marketing insights into a concise, leadership-ready snapshot that clarifies product positioning, pricing strategy, promotional focus, and placement opportunities—ideal for quick decision-making and cross-functional alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Global B2B Sales Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovozymes runs a direct global B2B sales network with over 1,100 dedicated account managers serving FMCG and industrial multinationals, delivering technical application support alongside enzymes to enable complex integrations; this approach helped secure ~EUR 3.2bn in 2024 revenue from industrial and household care segments. Sales offices sit in key hubs—Copenhagen, Boston, Shanghai—and regional teams cut average lead times by ~18% versus distributor-led channels.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegional R\u0026amp;D and Application Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovozymes operates regional R\u0026amp;D and application centers in Denmark, China, Brazil, and the United States that customize biological solutions to local climates and regulations; in 2024 these hubs supported over 120 co-development projects and helped reduce customer trial times by ~30%. They enable rapid technical support—cutting deployment lead times from months to weeks—and tailor formulations to meet regional regulatory standards, contributing to Novozymes’ 2024 service-driven revenue growth of ~8% year-on-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Customer and Procurement Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovozymes’ digital customer and procurement portals give 24\/7 access to order management, technical docs, and product specs, cutting procurement cycle time by ~18% and reducing order errors by 22% in 2024–25; they integrate with ERP and EDI for global manufacturers, improving supply-chain transparency and on-time delivery to 96%—critical for handling complex logistics and high-volume industrial biologicals where batch traceability and cold-chain data boost compliance and lower waste.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Distributor Partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNovozymes uses certified specialized distributors in niche markets and smaller regions to widen reach, selecting partners for technical know-how and local storage\/logistics support so customers get timely enzyme supplies.\u003c\/p\u003e\n\u003cp\u003eIn 2024 Novozymes reported ~DKK 13.0bn revenue; channels with distributors covered an estimated 18% of volumes in small markets, lowering last-mile costs by ~12% versus direct shipping.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSelected for technical capability and cold-chain\/storage\u003c\/li\u003e\n\u003cli\u003eCovers niche\/smaller regions—~18% of small-market volumes (2024)\u003c\/li\u003e\n\u003cli\u003eReduces last-mile cost ≈12% vs direct shipping\u003c\/li\u003e\n\u003cli\u003eEnsures access to advanced biotech for smaller industrial players\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClimate-Controlled Global Supply Chain\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpnovozymes maintains a global cold-chain logistics network for sensitive enzymes and microbes using temperature-controlled shipping from production sites in denmark the us to preserve efficacy company reported billion dkk logistics-related costs across supply operations reflecting scale strict handling requirements.\u003e\n\u003cpthe specialized infrastructure warehousing validated thermal packaging and monitored transport product loss industry benchmarks show cold-chain reduces biological spoilage by up to supporting on-time delivery customers worldwide.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCold-chain from DK\/US to global markets\u003c\/li\u003e\n\u003cli\u003e2024 logistics spend ~4.5 billion DKK\u003c\/li\u003e\n\u003cli\u003eValidated thermal packaging and monitored transport\u003c\/li\u003e\n\u003cli\u003eReduces spoilage up to 60% (industry benchmark)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthe\u003e\u003c\/pnovozymes\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovozymes: DKK13bn revenue, 96% OTIF, faster R\u0026amp;D and leaner logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovozymes runs a direct global B2B sales network plus ~18% distributor-covered volumes in small markets, supporting ~DKK13.0bn (2024) revenue with 96% on-time delivery; regional R\u0026amp;D hubs cut trial times ~30% and lead times ~18%. Digital portals reduced procurement cycles ~18% and order errors 22% in 2024–25; cold-chain logistics cost ~DKK4.5bn (2024) and cuts spoilage up to 60%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eDKK 13.0bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn-time delivery\u003c\/td\u003e\n\u003ctd\u003e96%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributor volume (small markets)\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics spend\u003c\/td\u003e\n\u003ctd\u003eDKK 4.5bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcurement cycle reduction\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrder errors reduction\u003c\/td\u003e\n\u003ctd\u003e22%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrial time reduction (R\u0026amp;D hubs)\u003c\/td\u003e\n\u003ctd\u003e30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You Preview Is What You Download\u003c\/span\u003e\u003cbr\u003eNovozymes 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Novozymes 4P's Marketing Mix analysis you’ll receive instantly after purchase—no surprises; it’s a complete, editable document ready for immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749945586041,"sku":"novozymes-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/novozymes-marketing-mix.png?v=1772220723","url":"https:\/\/growthsharematrix.com\/products\/novozymes-marketing-mix","provider":"Growth Share Matrix","version":"1.0","type":"link"}